BIO and PhRMA back Acorda in patent appeal

17-08-2017

BIO and PhRMA back Acorda in patent appeal

ibreakstock / iStockphoto.com

The Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA), two trade groups representing US pharmaceutical companies, have backed Acorda in an appeal to the US Court of Appeals for the Federal Circuit.


BIO, PhRMA, amicus brief, Acorda, Ampyra, patent, patent invalidation, Alkermes, Apotex, Mylan, Teva, multiple sclerosis

More on this story

Four of Acorda’s Ampyra patents invalidated
03-04-2017

LSIPR